The point here is that despite the IPO failing and the cash issues now being critical you still have a company with regular and growing income and an FDA approved product that is best in practise.
Going to take a big paper hit but wont be compounding that by selling at a panic price.
...
Add to My Watchlist
What is My Watchlist?
